Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE)

ClinicalTrials.gov ID: NCT03950622

Public ClinicalTrials.gov record NCT03950622. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Adults 50 Years of Age or Older (PNEU-AGE)

Study identification

NCT ID
NCT03950622
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
1,205 participants

Conditions and interventions

Interventions

  • Prevnar 13® Biological
  • V114 Biological

Biological

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 12, 2019
Primary completion
Mar 29, 2020
Completion
Mar 29, 2020
Last update posted
Apr 25, 2021

2019 – 2020

United States locations

U.S. sites
14
U.S. states
9
U.S. cities
13
Facility City State ZIP Site status
Synexus ( Site 1001) Mesa Arizona 85206
Artemis Institute for Clinical Research ( Site 1012) San Diego California 92103
Indago Research & Health Center, Inc ( Site 1002) Hialeah Florida 33012
Research Centers of America, LLC ( Site 1014) Hollywood Florida 33024
Advanced Medical Research Institute ( Site 0117) Miami Florida 33174
Lakes Research LLC ( Site 1005) Miami Lakes Florida 33014
Alliance for Multispecialty Research, LLC ( Site 1008) Newton Kansas 67114
Wake Research Clinical Research Center of Nevada, LLC ( Site 1010) Las Vegas Nevada 89104
Rapid Medical Research, Inc. ( Site 1011) Cleveland Ohio 44122
Diagnostics Research Group ( Site 1000) San Antonio Texas 78229
Synexus ( Site 1009) San Antonio Texas 78229
J Lewis Research Inc / Foothill Family Clinic ( Site 1013) Salt Lake City Utah 84109
Charlottesville Medical Research Center, LLC ( Site 1003) Charlottesville Virginia 22911
Health Research of Hampton Roads, Inc. ( Site 1007) Newport News Virginia 23606

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03950622, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 25, 2021 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03950622 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →